Eric Sievers

Eric Sievers

2558
被引用次数：19180
leukemia lymphoma antibody drug conjugates CD47 immuno-oncology
Gonçalo Bernardes

Gonçalo Bernardes

Yusuf Hamied Department Chemistry, University of Cambridge
在 cam.ac.uk 的电子邮件经过验证
被引用次数：16486
Chemical Biology Protein Modification Antibody-drug Conjugates Vaccines
Christoph Rader

Christoph Rader

Chief Technology Officer, Aethon Therapeutics, Inc.
在 aethontx.com 的电子邮件经过验证
被引用次数：14431
Antibody Therapeutics Antibody Engineering Phage Display Antibody-Drug Conjugates Bispecific Antibodies
Christian Steinkuhler

Christian Steinkuhler

italfarmaco, Exiris
在 italfarmaco.com 的电子邮件经过验证
被引用次数：10670
enzymology epigenetics antibody drug conjugates
David Lee

David Lee

Abbvie Inc.
在 abbott.com 的电子邮件经过验证
被引用次数：10233
antibody drug conjugates therapeutic antibodies biosimilars SITRS SILAC
Carmay Lim

Carmay Lim

Scientific Consultant, Immunwork, Inc. and TE Meds, Inc.
在 gate.sinica.edu.tw 的电子邮件经过验证
被引用次数：10057
peptide drugs antibody-drug conjugates antibody-radionuclide conjugates drug design
Amit Kumar

Amit Kumar

Abbott Diagnostics
在 abbott.com 的电子邮件经过验证
被引用次数：7037
Bioconjugation Organic chemistry Organic synthesis Radiochemistry Antibody drug conjugates
Timothy B. Lowinger

Timothy B. Lowinger

CSO, Mersana Therapeutics
在 mersana.com 的电子邮件经过验证
被引用次数：6671
antibody drug conjugates medicinal chemistry oncology drug discovery
Thomas Pillow

Thomas Pillow

Genentech
在 gene.com 的电子邮件经过验证
被引用次数：5556
chemistry antibody-drug conjugates
Jin Wang

Jin Wang

Michael E. DeBakey, MD, Professor in Pharmacology, Baylor College of Medicine
在 bcm.edu 的电子邮件经过验证
被引用次数：5198
Chemical Biology Drug Discovery Targeted Protein Degradation Antibody Drug Conjugates
1 - 10